The normal and cancer groups presented significantly different expression levels of BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, ERBB2, MSH2, PALB2, PTEN, and TP53 (Supplementary Fig. 6A). This evidence concerns the gene MSH2 and cancer.